Telmisartan 40 mg Tablets

Adult dose

Essential Hypertension Adults: Telmisartan 40 mg should be taken orally once daily with water, with or without regard to meals. Depending on the patient, 20 mg once daily may be sufficient. If necessary, it may be increased up to 80 mg once daily, with maximum blood pressure-lowering effect typically occurring 4 to 8 weeks after dose adjustment. Reduction of Cardiovascular Disease Risk Adults: It is recommended to take this medication 80 mg orally once daily with water, with or without regard to meals. The effects on reducing morbidity and mortality from cardiovascular diseases at doses below 80 mg are not known. It is recommended to monitor blood pressure when starting treatment with this medication for the purpose of reducing cardiovascular disease risk, and appropriate adjustment of antihypertensive therapy may be necessary.

This medication can cause severe damage or even death to the fetus or newborn if administered to pregnant women, so treatment should be stopped immediately upon confirmation of pregnancy. It should not be used in individuals with known allergic reactions to this drug, pregnant or breastfeeding women, those with severe liver impairment, patients with certain hereditary angioedema, and patients with diabetes or severe renal impairment. Elderly patients or those with high serum potassium levels, mild liver impairment, cardiovascular diseases, gastrointestinal diseases, renal artery hypertension, and severe renal impairment should use this medication cautiously. Various side effects may occur during treatment, including infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological abnormalities, arrhythmias, hypotension, respiratory difficulties, gastrointestinal disorders, liver dysfunction, skin rashes, muscle pain, and renal impairment. Immediate consultation with a physician is necessary if any unusual symptoms appear. Particular attention should be paid to conditions such as excessively low blood pressure, liver dysfunction, worsening renal function, severe allergic reactions, angioedema, interstitial pneumonia, and rhabdomyolysis. Patients with impaired renal function should have their serum potassium and creatinine levels regularly monitored, and those with volume depletion or sodium deficiency should improve their condition before administration to prevent hypotensive symptoms. Caution is required if taken with other medications affecting the renin-angiotensin-aldosterone system, as the risk of hypotension, hyperkalemia, and renal function deterioration may increase and should be closely monitored by healthcare professionals during concomitant use. It is advisable not to take this medication for 24 hours before surgery, and caution should be exercised in patients with gastrointestinal disorders due to the risk of gastrointestinal bleeding. This medication may cause dizziness or fainting while driving or operating machinery, and it should not be used in patients with fructose intolerance due to the presence of sorbitol. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are advised to discontinue breastfeeding while taking this medication. It is not recommended for children under 18 years of age, as safety and effectiveness have not been established. In the case of overdose, hypotension, arrhythmias, dizziness, or renal failure may occur, so immediate medical attention is necessary, and blood pressure and renal function should be monitored frequently. This medication should be stored out of reach of children and kept sealed until administration.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweats, paleness, anaphylactic reactions, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, severe skin reactions, shortness of breath, asthma attacks, respiratory abnormalities coupled with cough and fever, liver abnormalities (jaundice), yellowing of skin or eyes, profound malaise, sudden and severe headache, thunderclap headache, rash

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.

Appearance

White or nearly white, round, biconvex tablet

Package unit

10 tablets/blister X 3, 100 tablets/bottle